Hyperion DeFi, Inc. (NASDAQ:HYPD – Get Free Report) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,211,749 shares, a decrease of 40.9% from the March 15th total of 2,051,296 shares. Currently, 11.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 443,659 shares, the short-interest ratio is presently 2.7 days.
Analysts Set New Price Targets
A number of equities research analysts have commented on HYPD shares. Chardan Capital set a $7.75 price target on Hyperion DeFi and gave the company a “buy” rating in a report on Wednesday, December 24th. Cantor Fitzgerald raised Hyperion DeFi to a “strong-buy” rating in a research note on Thursday, April 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperion DeFi in a research report on Thursday, January 22nd. Finally, Zacks Research downgraded Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research note on Monday, March 30th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Hyperion DeFi presently has an average rating of “Hold” and an average price target of $5.88.
Check Out Our Latest Research Report on HYPD
Hedge Funds Weigh In On Hyperion DeFi
Hyperion DeFi Price Performance
Shares of NASDAQ:HYPD traded up $0.30 during midday trading on Wednesday, reaching $3.86. 268,925 shares of the company were exchanged, compared to its average volume of 339,153. The company has a current ratio of 2.68, a quick ratio of 2.68 and a debt-to-equity ratio of 0.19. The stock has a market cap of $43.97 million, a PE ratio of -0.33 and a beta of 2.62. The business’s fifty day moving average is $3.46 and its two-hundred day moving average is $4.57. Hyperion DeFi has a one year low of $1.02 and a one year high of $17.18.
Hyperion DeFi (NASDAQ:HYPD – Get Free Report) last announced its quarterly earnings results on Thursday, March 26th. The company reported ($7.76) EPS for the quarter. The business had revenue of $0.50 million for the quarter. As a group, analysts predict that Hyperion DeFi will post -41.6 earnings per share for the current year.
About Hyperion DeFi
Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.
Featured Articles
Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.
